VCP
FLGT icon

Verus Capital Partners’s Fulgent Genetics FLGT Stock Holding History

Verus Capital Partners’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$4K Hold
385
– – ﹤0.01% 1225
2019
Q4 		$5K Buy
+385
New +$4.58K ﹤0.01% 1300

Other funds holding FLGT

CFW
CA Family Wealth Beverly Hills, California $94.9M AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
RJT
Raymond James Trust St. Petersburg, Florida $4.6B AUM 33.54% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Verus Capital Partners's FLGT Position: Q1 2020 in Review

Verus Capital Partners held its Fulgent Genetics (FLGT) position steady in Q1 2020 at 385 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1225.

Verus Capital Partners first reported a position in FLGT in Q4 2019 and has held it in 2 quarters since. The position peaked at $5K in Q4 2019. 75 funds tracked by Wall St. Rank hold FLGT as of Q1 2020.

  • Verus Capital Partners held 385 shares of Fulgent Genetics worth $4K as of Q1 2020.
  • Verus Capital Partners left its Fulgent Genetics share count unchanged in Q1 2020.
  • Fulgent Genetics made up ﹤0.01% of Verus Capital Partners's portfolio in Q1 2020, its #1225 holding.
  • Verus Capital Partners first reported a position in Fulgent Genetics in Q4 2019 and has held it in 2 quarters since.
  • Verus Capital Partners's Fulgent Genetics position peaked at $5K in Q4 2019.
  • 75 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.